What Is Polyposis Syndrome Types Risks And Screening?

Polyposis syndrome is an inherited condition that causes dozens to thousands of polyps to grow in the colon and sometimes in other parts of the digestive tract. These polyps are not cancerous at first, but over time many of them can turn into colorectal cancer. The two main types are familial adenomatous polyposis (FAP) and MUTYH-associated polyposis (MAP). Regular screening with colonoscopy starting in childhood or the teenage years is the most important step to prevent cancer. Genetic testing can identify who carries the gene mutation and needs early surveillance.

What Is Polyposis Syndrome?

Polyposis syndrome refers to a group of genetic disorders that make a person highly prone to developing multiple polyps in the colon and rectum. Most polyposis syndromes are caused by inherited mutations in specific genes that control cell growth. When these genes do not work correctly, cells in the lining of the colon grow too quickly and form polyps.

Polyps are growths that stick out from the inner wall of the colon. Most colon polyps are benign at first, but some types can become cancerous if left alone. In polyposis syndrome, the large number of polyps dramatically raises the lifetime risk of colorectal cancer. Some syndromes also increase the risk of polyps and cancer in other organs such as the stomach, small intestine, and thyroid.

Not all polyposis syndromes are the same. Some cause hundreds or thousands of polyps by the teenage years, while others produce fewer polyps that appear later in life. The specific gene involved, the number of polyps, and the age of onset help doctors classify the type.

What Are the Main Types of Polyposis Syndrome?

The most common types of polyposis syndrome are familial adenomatous polyposis (FAP), attenuated FAP, and MUTYH-associated polyposis (MAP). Less common types include Peutz-Jeghers syndrome, juvenile polyposis syndrome, and serrated polyposis syndrome. This article focuses on the adenomatous types because they carry the highest colorectal cancer risk.

Familial adenomatous polyposis (FAP) is caused by a mutation in the APC gene. People with classic FAP develop hundreds to thousands of colorectal polyps, usually starting in the teenage years. Without treatment, nearly everyone with FAP develops colorectal cancer by age 40. Surgery to remove the colon is typically recommended in the 20s.

Attenuated FAP is a milder form caused by certain APC mutations. People develop fewer polyps – usually between 10 and 100 – and the polyps appear later in life. Cancer risk is still high, but the average age of diagnosis is after 50. Screening still needs to begin in young adulthood.

MUTYH-associated polyposis (MAP) is caused by mutations in both copies of the MUTYH gene. It is inherited in an autosomal recessive pattern, meaning both parents must pass on a mutation. The polyp count and cancer risk are similar to attenuated FAP. MAP may be underdiagnosed because it does not always follow a clear family history.

What Are the Risks of Polyposis Syndrome?

The most serious risk is colorectal cancer. In classic FAP, the cancer risk approaches 100% by age 40 if the colon is not removed. In attenuated FAP and MAP, the lifetime risk is still very high – estimated at 70% to 90% – but cancer typically occurs after age 50.

People with FAP also face increased risks for other cancers. These include duodenal cancer, ampullary cancer, pancreatic cancer, thyroid cancer, and hepatoblastoma in children. Extra-colonic features such as desmoid tumors, osteomas, dental abnormalities, and congenital hypertrophy of the retinal pigment epithelium (CHRPE) can help identify the syndrome before polyps appear.

In MAP, the main cancer risk is colorectal, though some studies suggest a slightly higher risk for other cancers like ovarian and bladder. The risk is not as well defined as in FAP.

Without screening, polyposis syndromes can go unnoticed until cancer has already developed. Many people with these syndromes have a family history of colon cancer at a young age, but about 20% to 30% of cases are new mutations with no family history.

When and How Should Screening Start?

Screening for polyposis syndrome begins with genetic testing. Anyone with a first-degree relative (parent, sibling, or child) who has a known polyposis gene mutation should consider genetic counseling and testing. In families with no known mutation but a strong history of multiple polyps or early colon cancer, testing can still be helpful.

For people who test positive for a polyposis gene mutation, colonoscopy is the standard screening tool. In classic FAP, the first colonoscopy should be around age 10 to 15, or earlier if symptoms are present. The exam is repeated every one to two years. Once polyps start to appear, the gastroenterologist will count and remove them if possible. The frequency of screening depends on the number and size of polyps.

For attenuated FAP and MAP, screening begins later – around age 18 to 20 – with a colonoscopy every one to two years. In both types, upper endoscopy to check for duodenal polyps is also recommended, usually starting slightly later or at the same time as colonoscopy.

Because these conditions are rare, screening should be done at a medical center with experience managing hereditary polyposis syndromes. Many centers have a multidisciplinary team that includes gastroenterologists, genetic counselors, surgeons, and dietitians.

What Other Screening or Prevention Options Exist?

For people with classic FAP, prophylactic colectomy is the standard of care once polyps become too numerous to manage with colonoscopy alone. The goal is to remove the colon before cancer develops. Two main surgical options exist: total proctocolectomy with ileal pouch-anal anastomosis (IPAA) or colectomy with ileorectal anastomosis. The choice depends on the number of rectal polyps and patient preference. After surgery, surveillance of the remaining rectum or pouch continues.

In attenuated FAP and MAP, the goal is to keep the colon through regular colonoscopy and polyp removal for as long as safely possible. Colectomy is considered when the number, size, or pathology of polyps becomes unmanageable or when cancer is found.

Chemoprevention – using drugs to prevent polyps – has been studied, but no medication is currently recommended for routine use. Some research suggests that sulindac and celecoxib can reduce polyp number and size in FAP, but the effect is temporary and does not eliminate cancer risk. Celecoxib also carries cardiovascular risks. No drug has been shown to replace colonoscopy or surgery.

Lifestyle measures such as a high-fiber diet, regular exercise, and avoiding smoking are sensible for general health, but there is no good evidence that they prevent polyps in polyposis syndrome.